`571-272-7822
`
`Paper 21
`Entered: September 1, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`VALVE CORPORATION,
`Petitioner,
`
`v.
`
`IRONBURG INVENTIONS LTD.,
`Patent Owner.
`____________
`
`Cases
`IPR2017-00136 (Patent 8,641,525 B2)
`IPR2017-00137 (Patent 9,089,770 B2)
`
`Before PHILLIP J. KAUFFMAN, MEREDITH C. PETRAVICK, and
`MITCHELL G. WEATHERLY Administrative Patent Judges.
`
`KAUFFMAN, Administrative Patent Judge.
`
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`Case IPR2017-00136 (Patent 8,641,525 B2)
`Case IPR2017-00137 (Patent 9,089,770 B2)
`
`
`
`
`At Petitioner’s request, a call was held with the panel and counsel for
`
`each party on August 31, 2017. Petitioner requests guidance regarding cross
`
`examination of Patent Owner’s expert, Dr. Stevick.
`
`
`
`BACKGROUND
`
`Patent Owner filed a Declaration from Dr. Stevick in both
`
`proceedings.1
`
`On August 11, 2017, Petitioner filed a Notice of Deposition of
`
`Dr. Stevick for both proceedings.2 The Notice states that the deposition will
`
`begin on September 6, 2017, and will continue from day-to-day until
`
`completed.
`
`On August 27, 2017, Petitioner filed the Petitioner’s Reply in
`
`IPR2017-00136 (Paper 20), but did not file the Reply for IPR2017-00137.
`
`
`
`ISSUE
`
`
`
`With regard to IPR2017-00137, the parties agree that the Deposition
`
`of Dr. Stevick should be carried out as scheduled.
`
`Patent Owner contends that in these circumstances, Dr. Stevick is
`
`unavailable for cross-examination regarding IPR2017-00136 pursuant to
`
`37 C.F.R. § 42.53(b)(1).
`
`Petitioner contends that 37 C.F.R. § 42.53(b)(1) is not applicable to
`
`this situation, and that the cross-examination should proceed as scheduled.
`
`
`
`
`
`
`1 Exhibits 2002 and 2032 in each proceeding.
`2 Papers 18 and 19 of each proceeding.
`
`2
`
`
`
`Case IPR2017-00136 (Patent 8,641,525 B2)
`Case IPR2017-00137 (Patent 9,089,770 B2)
`
`ANALYSIS
`
`
`
`We agree with Petitioner that Patent Owner’s reliance upon 37 C.F.R.
`
`§ 42.53(b)(1) is misplaced because that rule deals with uncompelled direct
`
`testimony, not cross examination testimony. However, the Scheduling
`
`Order in this case states that the period for cross-examination, “ends no later
`
`than a week before the filing date for any paper in which the cross-
`
`examination testimony is expected to be used.” Paper 13 ¶ B.2. The filing
`
`date for Petitioner’s Reply in IPR2017-00136 was August 27, 2017, and
`
`consequently the period for cross-examination has ended. Petitioner elected
`
`to file the Reply early, and in doing so closed the period for cross-
`
`examination.
`
`
`
`We recognize that these proceedings are related, and consequently
`
`cross-examination of Dr. Stevick with regard to IPR2017-00137 may reveal
`
`information relevant to IPR2017-00136. Should this situation arise, we are
`
`willing to consider if the Deposition taken for IPR2017-00137 and an
`
`associated paper may be filed in IPR2017-00136.
`
`
`
`Accordingly, it is ORDERED that the cross-examination of
`
`Dr. Stevick will proceed as scheduled for and IPR2017-00137, but
`
`Dr. Stevcik may not be cross-examined with regard to IPR2017-00136.
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`
`
`Case IPR2017-00136 (Patent 8,641,525 B2)
`Case IPR2017-00137 (Patent 9,089,770 B2)
`
`PETITIONER:
`
`Joshua Harrison
`josh@bhiplaw.com
`
`Reynaldo Barcelo
`rey@bhiplaw.com
`
`
`PATENT OWNER:
`
`Ehab Samuel
`Esamuel-ptab@manatt.com
`
`Danielle Mihalkanin
`dmihalkanin@manatt.com
`
`
`
`
`4
`
`